Pathogenesis of lassa fever in cynomolgus macaques

Virology Journal

Volumn 8, Issue , 2011, Pages

  Hensley, Lisa E ^a   Smith, Mark A ^a   Geisbert, Joan B ^b,c   Fritz, Elizabeth A ^b,c   Daddario Dicaprio, Kathleen M ^a   Larsen, Tom ^a   Geisbert, Thomas W ^b,c  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN;

ADRENAL CORTEX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; DENDRITIC CELL; DISEASE COURSE; ENDOTHELIUM CELL; FIBRIN DEPOSITION; KUPFFER CELL; LASSA FEVER; LASSA VIRUS; LIVER CELL; MACACA; MENINGOENCEPHALITIS; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PILOT STUDY; PRIMATE; PROPHYLAXIS; VIRUS HEMORRHAGIC FEVER; ANIMAL; ANIMAL ANATOMY; ANIMAL DISEASE; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MICROSCOPY; PATHOGENICITY; PATHOLOGY; PRIMATE DISEASE; VIROLOGY;

ANIMALIA; LASSA VIRUS; MACACA; MACACA FASCICULARIS; PRIMATES;

ANIMAL EXPERIMENTATION; ANIMAL STRUCTURES; ANIMALS; IMMUNOHISTOCHEMISTRY; LASSA FEVER; LASSA VIRUS; MACACA FASCICULARIS; MICROSCOPY; PRIMATE DISEASES;

EID: 79955651975     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-205     Document Type: Article

References (49)

1. A prospective study of the epidemiology and ecology of Lassa fever. JB McCormick PA Webb JW Krebs KM Johnson ES Smith, J Infect Dis 1987 155 437 444 10.1093/infdis/155.3.437 3805771 (Pubitemid 17032800)
2. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. SP Fisher-Hoch O Tomori A Nasidi GI Perez-Oronoz Y Fakile L Hutwagner JB McCormick, Br Med J 1995 311 857 859
3. Lassa fever imported to England. Communicable Disease Surveillance Centre, Commun Dis Rep CDR Weekly 2000 10 99
4. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. H Schmitz B Kohler T Laue C Drosten PJ Veldkamp S Gunther P Emmerich HP Geisen K Fleischer MF Beersma A Hoerauf, Microbes Infect 2002 4 43 50 10.1016/S1286-4579(01)01508-8 11825774 (Pubitemid 34127990)
5. A man with fatal Lassa fever following a stay in Sierre Leone. PJ Veldkamp EF Schippers, Ned Tijdschr Geneeskd 2002 146 2201 2204 12467165 (Pubitemid 35396582)
6. Imported Lassa fever in Germany: surveillance and management of contact persons. WH Haas T Breuer G Pfaff H Schmitz P Kohler M Asper P Emmerich C Drosten U Golnitz K Fleischer S Gunther, Clin Infect Dis 2003 36 1254 1258 10.1086/374853 12746770 (Pubitemid 36629934)
7. Imported Lassa fever - New Jersey, 2004. Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep 2004 53 894 897 15457145
8. A fatal case of Lassa fever in London, January 2009. A Kitching S Addiman S Cathcart L Bischop D Krahe M Nicholas J Coakley G Lloyd T Brooks D Morgan D Turbitt, Euro Surveill 2009 14 19117 19215723
9. Imported Lassa fever, Pennsylvania, USA, 2010. V Amorosa A MacNeil R McConnell A Patel KE Dillon K Hamilton BR Erickson S Campbell B Knust D Cannon D Miller C Manning PE Rollin ST Nichol, Emerg Infect Dis 2010 16 1598 600 20875288
10. Exotic emerging viral diseases: progress and challenges. TW Geisbert PB Jahrling, Nat Med 2004 10 12 Suppl 110 121 15577929
11. Lassa fever. Effective therapy with ribavirin. JB McCormick IJ King PA Webb CL Scribner RB Craven KM Johnson LH Elliott R Belmont-Williams, N Engl J Med 1986 314 20 26 10.1056/NEJM198601023140104 3940312 (Pubitemid 16183064)
12. Ribavirin for Lassa fever postexposure prophylaxis. CM Hadi A Goba SH Khan J Bangura M Sankoh S Koroma B Juana A Bah M Coulibaly DG Bausch, Emerg Infect Dis 2010 16 2009 11 21122249
13. Pathogenesis of Lassa virus infection in guinea pigs. PB Jahrling S Smith RA Hesse JB Rhoderick, Infect Immun 1982 37 771 778 6749685 (Pubitemid 12100066)
14. Pathology and pathogenesis of arenavirus infections. DH Walker FA Murphy, Curr Top Microbiol Immunol 1987 133 89 113 3030664
15. Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. DH Walker H Wulff JV Lange FA Murphy, Bull World Health Organ 1975 52 523 534 821625
16. Experimental Lassa virus infection in the squirrel monkey. DH Walker H Wulff FA Murphy, Am J Pathol 1975 80 261 78 1163630
17. Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. MP Kiley JV Lange KM Johnson, Lancet 1979 2 738 90820
18. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. PB Jahrling RA Hesse GA Eddy KM Johnson RT Callis EL Stephen, J Infect Dis 1980 141 580 589 10.1093/infdis/141.5.580 6768812 (Pubitemid 10109827)
19. Pathology of Lassa virus infection in the rhesus monkey. RT Callis PB Jahrling A DePaoli, Am J Trop Med Hyg 1982 31 1038 1045 7125056 (Pubitemid 12030540)
20. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. DH Walker KM Johnson JV Lange JJ Gardner MP Kiley JB McCormick, J Infect Dis 1982 146 360 8 10.1093/infdis/146.3.360 6286795 (Pubitemid 12031213)
21. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. PB Jahrling CJ Peters, Infect Immun 1984 44 528 33 6715049 (Pubitemid 14139025)
22. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. PB Jahrling CJ Peters EL Stephen, J Infect Dis 1984 149 420 427 10.1093/infdis/149.3.420 6715898 (Pubitemid 14138245)
23. Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys. JV Lange SW Mitchell JB McCormick DH Walker BL Evatt RR Ramsey, Am J Trop Med Hyg 1985 34 999 1007 4037187 (Pubitemid 16241065)
24. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. SP Fisher-Hoch SW Mitchell DR Sasso JV Lange R Ramsey JB McCormick, J Infect Dis 1987 155 465 474 10.1093/infdis/155.3.465 3543155 (Pubitemid 17032803)
25. Experimental studies of arenaviral hemorrhagic fevers. CJ Peters PB Jahrling CT Liu RH Kenyon KT McKee Jr JG Barrera Oro, Curr Top Microbiol Immunol 1987 134 5 68 3034512
26. Hematologic dysfunction in Lassa fever. S Fisher-Hoch JB McCormick D Sasso RB Craven, J Med Virol 1988 26 127 135 10.1002/jmv.1890260204 3183637
27. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. SP Fisher-Hoch JB McCormick D Auperin BG Brown M Castor G Perez S Ruo A Conaty L Brammer S Bauer, Proc Natl Acad Sci USA 1989 86 317 21 10.1073/pnas.86.1.317 2911575 (Pubitemid 19036377)
28. Experimental Lassa fever in hamadryas baboons. AA Evseev VI Dvoretskaia GV Bogatikov VA Pshenichnov RM Mustafin, Vopr Virusol 1991 36 150 152 1882523
29. Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys. JB McCormick SW Mitchell MP Kiley S Ruo SP Fisher-Hoch, J Med Virol 1992 37 1 7 1619397
30. Effective vaccine for Lassa fever. SP Fisher-Hoch L Hutwagner B Brown JB McCormick, J Virol 2000 74 6777 83 10.1128/JVI.74.15.6777-6783.2000 10888616 (Pubitemid 30470660)
31. Development of a new rapid vaccine for the prevention of Lassa fever. TW Geisbert S Jones EA Fritz AC Shurtleff JB Geisbert R Liebscher A Grolla U Stroher KM Daddario MC Guttieri BR Mothe LE Hensley PB Jahrling H Feldmann, PLoS Med 2005 2 183 10.1371/journal.pmed.0020183 15971954
32. Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. R Carrion Jr K Brasky K Mansfield C Johnson M Gonzales A Ticer I Lukashevich S Tardif J Patterson, J Virol 2007 81 6482 6490 10.1128/JVI.02876-06 17409137 (Pubitemid 46878053)
33. Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. IS Lukashevich R Carrion Jr MS Salvato K Mansfield K Brasky J Zapata C Cairo M Goicochea GE Hoosien A Ticer J Bryant H Davis R Hammamieh M Mayda M Jett J Patterson, Vaccine 2008 26 5246 54 10.1016/j.vaccine.2008.07.057 18692539
34. Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. S Baize P Marianneau P Loth S Reynard A Journeaux M Chevallier N Tordo V Deubel H Contamin, J Virol 2009 83 5890 903 10.1128/JVI.01948-08 19297492
35. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. LE Hensley EL Stevens SB Yan JB Geisbert WL Macias T Larsen KM Daddario-DiCaprio GH Cassell PB Jahrling TW Geisbert, J Infect Dis 2007 196 Suppl 2 390 S399 17940975
36. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. JD Frame JM Baldwin Jr DJ Gocke JM Troup, Am J Trop Med Hyg 1970 19 670 6 4246571
37. The pathology of Lassa fever. GM Edington HA White, Trans R Soc Trop Med Hyg 1972 66 381 9 10.1016/0035-9203(72)90268-4 5046378
38. The pathology of human Lassa fever. WC Winn Jr DH Walker, Bull World Health Organ 1975 52 535 45 1085209
39. Lassa virus hepatitis. Observations on a fatal case from the 1972 Sierra Leone epidemic. WC Winn Jr TP Monath FA Murphy SG Whitfield, Arch Pathol 1975 99 599 604 1227472
40. Lassa fever - an autopsy report from the eastern part of Nigeria. SE Ikerionwu K Sato KC Katchy AA Suseelan, J Trop Med Hyg 1978 81 134 6 702621 (Pubitemid 9026551)
41. Clinical observations in 42 patients with Lassa fever. J Knobloch JB McCormick PA Webb M Dietrich HH Schumacher E Dennis, Tropenmed Parasitol 1980 31 389 398 7233535 (Pubitemid 11185282)
42. Pathologic and virologic study of fatal Lassa fever in man. DH Walker JB McCormick KM Johnson PA Webb G Komba-Kono LH Elliott JJ Gardner, Am J Pathol 1982 107 349 56 7081389 (Pubitemid 12084836)
43. Lassa virus hepatitis: a study of fatal Lassa fever in humans. JB McCormick DH Walker IJ King PA Webb LH Elliott SG Whitfield KM Johnson, Am J Trop Med Hyg 1986 35 401 7 3953952 (Pubitemid 16055415)
44. Lassa fever encephalopathy: clinical and laboratory findings. D Cummins D Bennett SP Fisher-Hoch B Farrar SJ Machin JB McCormick, J Trop Med Hyg 1992 95 197 201 1597876
45. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. S Gunther B Weisner A Roth T Grewing M Asper C Drosten P Emmerich J Petersen M Wilczek H Schmitz, J Infect Dis 2001 184 345 9 10.1086/322033 11443561 (Pubitemid 32662182)
46. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. S Mahanty DG Bausch RL Thomas A Goba A Bah CJ Peters PE Rollin, J Infect Dis 2001 183 1713 21 10.1086/320722 11372023 (Pubitemid 32523233)
47. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. TW Geisbert LE Hensley T Larsen HA Young DS Reed JB Geisbert DP Scott E Kagan PB Jahrling KJ Davis, Am J Pathol 2003 163 2347 2370 10.1016/S0002-9440(10)63591-2 14633608 (Pubitemid 37466478)
48. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. S Mahanty K Hutchinson S Agarwal M McRae PE Rollin B Pulendran, J Immunol 2003 170 2797 801 12626527 (Pubitemid 36302147)
49. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. S Baize J Kaplon C Faure D Pannetier MC Georges-Courbot V Deubel, J Immunol 2004 172 2861 9 14978087 (Pubitemid 38263671)